Labubu toys packaging are seen at a souvenir store in Krakow, Poland on August 21, 2025.Even Confucius is getting in on China's "blind box" craze.At the main temple in Beijing to China's greatest sage, the souvenir shops sell a range of "blind boxes," gifts packaged in such a way that buyers don't know exactly what variety of the item they're purchasing until after they commit.One popular blind box at the store is an ice cream treat with a blessing from Confucius. Worshippers pay $4.50 and, only after unwra ...

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, August 25th:TAT Technologies Ltd. (TATT) : This solutions and services provider to the commercial and military aerospace and ground defense industries has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.7% over the last 60 days.TAT’s shares gained 21.9% over the last three months compared with the S&P 500’s advance of 11.4%. The company possesses a M ...

Jensen Huang, CEO of Nvidia, is seen on stage next to a small robot during the Viva Technology conference dedicated to innovation and startups at Porte de Versailles exhibition center in Paris, France, on June 11, 2025.Nvidia announced Monday that its latest robotics chip module, the Jetson AGX Thor, is now on sale for $3,499 as a developer kit.The company calls the chip a "robot brain." The first kits ship next month, Nvidia said last week, and the chips will allow customers to create robots.After a compan ...

Core Viewpoint - A class action lawsuit has been filed against Nutex Health Inc. and certain officers for alleged violations of federal securities laws during the Class Period from August 8, 2024, to August 14, 2025, seeking damages for affected investors [1][2]. Company Overview - Nutex Health Inc. is a physician-led healthcare services company that operates through three divisions: a hospital division with 24 facilities across 11 states, a population health management division, and real estate [4]. - The company primarily operates as an out-of-network provider, generating over 90% of its net patient service revenue from third-party payors, including commercial insurance and workers' compensation [4]. Legislative Context - The No Surprises Act (NSA), effective January 1, 2022, was enacted to prevent surprise out-of-network billing, requiring private health plans to cover out-of-network claims at in-network cost-sharing rates [6]. - The NSA established an independent dispute resolution (IDR) process for determining out-of-network payment amounts when negotiations fail [7]. Financial Impact - Following the implementation of the NSA, Nutex's average payment from insurers for emergency services declined by approximately 30%, with a 37% reduction for physician services reported in March 2023 [8]. - In 2024, Nutex's total revenue increased by $232.3 million to $479.9 million, with the arbitration process contributing approximately $169.7 million to this revenue increase [9]. Internal Control Issues - Nutex has acknowledged material weaknesses in its internal controls over financial reporting, including ineffective design and implementation of controls related to financial processes [9]. - The company has stated it is in the process of remediating these weaknesses [9]. Allegations and Lawsuits - The lawsuit alleges that Nutex made materially false and misleading statements regarding its business operations and financial prospects, including claims about the sustainability of revenues from its engagement with HaloMD in the IDR process [9]. - Blue Orca Capital's report accused HaloMD of engaging in fraudulent schemes to inflate payments from insurance companies, which could impact Nutex's financial stability [10][11]. Stock Price Reaction - Following the publication of the Blue Orca Report, Nutex's stock price fell by $11.18 per share (10.05%) on July 22, 2025, and further declined by $18.22 per share (16.39%) after the company announced a delay in filing its Form 10-Q on August 15, 2025 [11][13]. Recent Developments - On August 21, 2025, Nutex filed a Current Report with the SEC indicating that certain financial statements would need to be restated due to improper treatment of non-cash obligations [14].

Core Viewpoint - American Eagle Outfitters Inc (NYSE:AEO) has been downgraded by BofA Global Research to "underperform" from "neutral," with a price target cut from $11 to $10, citing tariff pressures and weakening sales momentum despite some short-term boosts from back-to-school shopping and a marketing campaign featuring Sydney Sweeney [1] Group 1: Analyst Ratings and Market Sentiment - Analysts are predominantly bearish on AEO, with only one out of 13 brokerages rating it as a "strong buy," while 10 have a "hold" rating and two a "strong sell" [2] - The 12-month consensus price target is $11.88, indicating a 4.4% discount to current trading levels [2] - Options market activity shows a bearish sentiment, with 38,000 puts exchanged, significantly higher than the average put volume, compared to only 3,605 calls [2] Group 2: Stock Performance and Short Interest - AEO's stock price is currently at $12.42, down 3.4%, and has decreased by 25.3% since the beginning of the year [1][3] - The $12 level has acted as a support level, limiting further losses [3] - Short interest has increased by 57.9% over the last two weeks, now representing 17.6% of the stock's available float, indicating potential for a short squeeze [3]

Hesai Group Sponsored ADR (HSAI) closed the last trading session at $23.26, gaining 9.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $30.15 indicates a 29.6% upside potential.The mean estimate comprises eight short-term price targets with a standard deviation of $4.76. While the lowest estimate of $23.30 indicates a 0.2% increase from the current price level, the most optimisti ...

Group 1: Stock Performance and Price Targets - InfuSystems Holdings, Inc. (INFU) closed at $9.57, with a 59.2% gain over the past four weeks, and a mean price target of $13.5 indicating a 41.1% upside potential [1] - The average of five short-term price targets ranges from a low of $12.00 to a high of $15.00, with a standard deviation of $1.41, suggesting a potential increase of 25.4% to 56.7% from the current price [2] - A tight clustering of price targets, indicated by a low standard deviation, suggests a high degree of agreement among analysts regarding the stock's price movement [9] Group 2: Earnings Estimates and Analyst Sentiment - Analysts show growing optimism regarding INFU's earnings prospects, as indicated by strong agreement in revising EPS estimates higher, which correlates with near-term stock price movements [11] - The Zacks Consensus Estimate for the current year has increased by 168.4% over the past month, with two estimates going higher and no negative revisions [12] - INFU holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for upside [13]

Backblaze, Inc. (BLZE) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, BLZE's 50-day simple moving average crossed above its 200-day simple moving average, known as a "golden cross."Considered an important signifier for a bullish breakout, a golden cross is a technical chart pattern that's formed when a stock's short-term moving average breaks above a longer-term moving average; the most common crossover involves the 50-day and the 2 ...

Shares of Superior Group (SGC) have gained 18.5% over the past four weeks to close the last trading session at $13.01, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $18 indicates a potential upside of 38.4%.The average comprises five short-term price targets ranging from a low of $14.00 to a high of $24.00, with a standard deviation of $4. While the lowest estimate indicates a ...

Remitly Global, Inc. (RELY) closed the last trading session at $19.05, gaining 12.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $27.11 indicates a 42.3% upside potential.The mean estimate comprises nine short-term price targets with a standard deviation of $3.48. While the lowest estimate of $21.00 indicates a 10.2% increase from the current price level, the most optimistic an ...